Open original FDA record ↗Recall record
- FDA identifier
- Z-1326-2021
- Company in FDA record
- Philips North America, LLC
- FDA record creation date
- Mar 30, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Fail to Comply with Chinese Standard YY1079-2008: Clauses 4.2.6 and 4.2.7.3. Range/accuracy of heart rate meter for pediatric mode-In pediatric mode, when the input signal rate is over 300 bpm, the indicated rate of the affected products will be lower than this upper limit
Source facts
- Action
- Philips Market Organizations are responsible for distributing the letters outside of the U.S. Letter issued on 3/23/21 , stating: Reason for correction, health risk and Action to be Taken by Customer/User states: This issue only happens on pediatric type patient with heartrate is greater than device claimed maximum heart rate 300 bpm. The device can continue to be used, however when using the monitor in the Pediatric category, patients at risk for tachycardia should be kept under close observation in accordance with existing product warnings described in the IFU. You may also consider to keep the default HR alarm limits or set tight HR alarm limits around the patients baseline HR for these patients Philip will send an engineer onsite to check the SW revision of your monitors. PHILIPS Subsequently a SW upgrade will be performed if your device is with the affected software revision. A Philips Healthcare representative will contact you to arrange for the correction.
- Initiated
- 2021-03-23
- Root cause
- Software design
- Terminated
- 2023-09-28
- Distribution
- International distribution in the country of China.
- Recall number
- Z-1326-2021
- Recall status
- Terminated
- CDRH record ID
- 185993
- FDA record created
- 2021-03-30
- Recall event number
- 87418